GILEAD CONNECTICUT INC has a total of 179 patent applications. It decreased the IP activity by 66.0%. Its first patent ever was published in 2006. It filed its patents most often in United States, EPO (European Patent Office) and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are SIGNAL PHARM LLC, CONN P JEFFREY and ESTEVE LABOR DR.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 23 | |
#2 | EPO (European Patent Office) | 18 | |
#3 | Republic of Korea | 13 | |
#4 | Australia | 11 | |
#5 | China | 11 | |
#6 | Canada | 9 | |
#7 | Hong Kong | 9 | |
#8 | Israel | 7 | |
#9 | Japan | 7 | |
#10 | New Zealand | 7 | |
#11 | Singapore | 6 | |
#12 | WIPO (World Intellectual Property Organization) | 6 | |
#13 | Mexico | 5 | |
#14 | Peru | 5 | |
#15 | African Regional Industrial Property Organization | 4 | |
#16 | Chile | 4 | |
#17 | EAPO (Eurasian Patent Organization) | 4 | |
#18 | Argentina | 3 | |
#19 | Brazil | 3 | |
#20 | Taiwan | 3 | |
#21 | Colombia | 2 | |
#22 | Costa Rica | 2 | |
#23 | Morocco | 2 | |
#24 | Republic of Moldova | 2 | |
#25 | Philippines | 2 | |
#26 | Ukraine | 2 | |
#27 | Uruguay | 2 | |
#28 | South Africa | 2 | |
#29 | Hungary | 1 | |
#30 | Malaysia | 1 | |
#31 | Serbia | 1 | |
#32 | El Salvador | 1 | |
#33 | Viet Nam | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Machines | |
#4 | Measurement | |
#5 | Biotechnology |
# | Name | Total Patents |
---|---|---|
#1 | Currie Kevin S | 99 |
#2 | Mitchell Scott A | 97 |
#3 | Lee Seung H | 92 |
#4 | Xu Jianjun | 90 |
#5 | Blomgren Peter A | 84 |
#6 | Kropf Jeffrey E | 81 |
#7 | Zhao Zhongdong | 65 |
#8 | Stafford Douglas G | 48 |
#9 | Stefanidis Dimitrios | 42 |
#10 | Schmitt Aaron C | 36 |
Publication | Filing date | Title |
---|---|---|
EA029281B1 | POLYMORPH OF Syk INHIBITORS | |
KR20160036590A | Formulation of syk inhibitors | |
US2013338142A1 | Imidazopyrazine syk inhibitors | |
US2013267496A1 | Imidazopyrazine syk inhibitors | |
CA2809662A1 | Pyridazinones, method of making, and method of use thereof | |
ZA201104182B | Imidazopyrazine syk inhibitors | |
KR20180062465A | Pyridone and aza-pyridone compounds and methods of use | |
CN104059073A | Imidazopyrizine Syk Inhibitors | |
UA110601C2 | Imidazopyrazines inhibitors syk | |
VN28228A1 | Imidazopyrazine Syk inhibitors | |
EP2365970A1 | Pyridazinones and their use as btk inhibitors | |
TW200914446A | Certain substituted amides, method of making, and method of use thereof | |
AU2007296563A1 | Substituted amides, method of making, and method of use thereof | |
AU2006204790A1 | 1,3-diaryl substituted ureas as modulators of kinase activity |